Results 31 to 40 of about 4,043 (198)

P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) [PDF]

Hemasphere, 2022
HemaSphere, Volume 6, Issue S3, Page 1080-1081, June 2022.
Kadia T, Ravandi F, Borthakur G, Jabbour E, Montalban-Bravo G, Adewale L, Pierce S, Lacke C, Brandt M, Short N, Jain N, Burger J, Ferrajoli A, Wierda W, Kantarjian H.   +14 more
europepmc   +2 more sources

Making Law Possible

, 2023
The Modern Law Review, Volume 86, Issue 3, Page 814-835, May 2023.
Sebastian Lewis
wiley   +1 more source

S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION

, 2022
HemaSphere, Volume 6, Issue S3, Page 50-51, June 2022.
N. Jain, P. Thompson, J. Burger, A. Ferrajoli, K. Takahashi, Z. Estrov, G. Borthakur, P. Bose, T. Kadia, N. Pemmaraju, K. Sasaki, M. Konopleva, E. Jabbour, N. Garg, X. Wang, R. Kanagal‐Shamanna, K. Patel, W. Wang, S. Wang, J. Jorgensen, W. Lopez, A. Ayala, W. Plunkett, V. Gandhi, H. Kantarjian, S. O'Brien, M. Keating, W. Wierda   +27 more
wiley   +1 more source

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T‐ACUTE LYMPHOBLASTIC LEUKEMIA/T‐LYMPHOBLASTIC LYMPHOMA (T‐ALL/LBL)

, 2022
HemaSphere, Volume 6, Issue S3, Page 265-266, June 2022.
F. Ravandi, E. Jabbour, N. Jain, T. Kadia, B. Gautam, M. Konopleva, W. Wierda, J. Burger, G. Issa, A. Maiti, H. Balkin, M. Kelly, R. Garris, P. Kebriaei, A. Ferrajoli, G. Garcia‐Manero, Y. Alvarado, N. Short, H. Kantarjian   +18 more
wiley   +1 more source

P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF MEASURABLE RESIDUAL DISEASE‐POSITIVE B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA

, 2022
HemaSphere, Volume 6, Issue S3, Page 268-269, June 2022.
J. Senapati, H. Kantarjian, N. Short, Y. Alvarado, J. Burger, N. Jain, M. Konopleva, F. Ravandi, C. DiNardo, L. Masarova, K. Sasaki, P. A. Thompson, A. Ferrajoli, J. O. Jacob, E. D. Mayor, A. M. Milton, C. Loiselle, R. S. Garris, E. J. Jabbour   +18 more
wiley   +1 more source

Entrevista com Luigi Ferrajoli

DESC - Direito, Economia e Sociedade Contemporânea, 2019
Entrevista a Luigi ...
Luigi Ferrajoli, José Antonio Siqueira Pontes, Pasquale Bronzo   +2 more
openaire   +3 more sources

P371: HYPER‐CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITHOUT INOTUZUMAB OZOGAMICIN, IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME‐NEGATIVE B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA

, 2022
HemaSphere, Volume 6, Issue S3, Page 271-272, June 2022.
N. Short, H. Kantarjian, F. Ravandi, M. Yilmaz, T. Kadia, P. Thompson, X. Huang, M. Konopleva, A. Ferrajoli, N. Jain, K. Sasaki, Y. Alvarado, G. Borthakur, C. Dinardo, M. Ohanian, W. Macaron, S. Kornblau, M. Zhao, M. Kwari, C. Loiselle, R. Delumpa, A. Milton, J. Rivera, S. Lewis, R. Garris, E. Jabbour   +25 more
wiley   +1 more source

Consideraciones extravagantes de un «jurista empírico»

Doxa, 2008
El autor destaca los aspectos de la obra de FERRAJOLI que son de particular interés para un «jurista empírico». En particular se trata el método axiomatizado, el cual aparece como satisfaciendo la exigencia de transparencia que requiere el ejercicio del ...
Senese, Salvatore
doaj   +1 more source

Principios, ponderación, y la separación entre derecho y moral: sobre el neoconstitucionalismo y sus críticos

Doxa, 2011
En el ensayo Constitucionalismo principialista y constitucionalismo garantista, Luigi Ferrajoli ofrece una oportuna clarificación teórica y conceptual sobre el así llamado neoconstitucionalismo.
Pino, Giorgio
doaj   +1 more source

P648: T CELL PHENOTYPIC CHANGES IN PARTICIPANTS OF A MULTIPHASE OPTIMIZATION STRATEGY (MOST) BEHAVIORAL INTERVENTION OF HEALTHY DIET AND EXERCISE IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

, 2022
HemaSphere, Volume 6, Issue S3, Page 546-547, June 2022.
M. Gordon, J. Crane, C. Y. Lee, S. Fares, K. Basen‐Engquist, M. Markofski, A. Ferrajoli, E. LaVoy   +7 more
wiley   +1 more source